Sanjivani Paranteral Share Price Today | Stock Price & Sanjivani Paranteral Share Screener
As of October 5, 2026, the live Sanjivani Paranteral share price (BSE: SANJIVIN) is ₹165.95, up 0.51% from the previous close, with shares trading between ₹165.35 and ₹172.95 in today's trading session, and a 52-week range of ₹129.30–₹239.65. Check SANJIVIN 52-week performance for the annual price range and momentum. Use the Sanjivani Paranteral stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sanjivani Paranteral opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹24 and net income of ₹3, with EBITDA of ₹4, an operating margin of 17.0% and a profit margin of 12.5%.
Sanjivani Paranteral Share Price Chart
Track the current stock price of Sanjivani Paranteral with an interactive chart. Analyse SANJIVIN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sanjivani Paranteral stock quote in one place.
The quote of ₹165.95 sits between the 52-week low of ₹129.30 and the 52-week high of ₹239.65, and the latest session moved 0.51% from the previous close.
Sanjivani Paranteral Company Profile - Fundamental Screener
Screen Sanjivani Paranteral company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANJIVIN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE860D01013.
Company Details
Classification
Identifiers and Leadership
Sanjivani Paranteral Balance Sheet Screener
Screen SANJIVIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹88, up from ₹78 in 2025.
Latest statistics put total assets at ₹88 and shareholder funds at ₹51, with a leverage ratio of 0.26.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
Assets |
|||
| Total Assets | 88 | 78 | 43 |
| Current Assets | 36 | 34 | 29 |
| Fixed Assets | 47 | 21 | 10 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 11 | 7 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 51 | 40 | 28 |
| Share Capital | 12 | 12 | 12 |
| Reserves & Surplus | 36 | 25 | 14 |
Sanjivani Paranteral Income Statement Screener - Profit & Revenue Analysis
Screen Sanjivani Paranteral income statement and profit fundamentals. Analyze SANJIVIN quarterly results. Sanjivani Paranteral reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹24 and net profit was ₹3, equal to earnings per unit of ₹2.03, at an operating margin of 17%.
In that period expenses were ₹20, interest cost ₹0 and tax ₹1. The next period listed, 2026-Mar, shows revenue of ₹14 and net profit of ₹1.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||
| Revenue | 24 | 14 | 22 | 16 | 18 | 19 | 18 | 19 | 17 | 13 | 15 |
| Expenses | 20 | 12 | 18 | 13 | 15 | 16 | 15 | 15 | 14 | 11 | 13 |
Operating Costs and Margins | |||||||||||
| EBITDA | 4 | 2 | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
| Operating Profit % | 17.00% | 12.00% | 17.00% | 15.00% | 15.00% | 14.00% | 15.00% | 16.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||
| Profit Before Tax | 3 | 1 | 4 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Net Profit | 3 | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| EPS | 2.03 | 0.49 | 2.21 | 1.33 | 1.46 | 1.84 | 1.62 | 1.96 | 1.47 | 1.08 | 1.65 |
Sanjivani Paranteral Cash Flow Screener - Liquidity Fundamentals
Screen SANJIVIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹0.
Over the same period, investing activities used ₹10 and financing activities provided ₹10.
| Item | 2026-March | 2025-March | 2024-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | 0 | 12 | -11 |
| Investing Activities | -10 | -22 | -12 |
Financing and Net Cash | |||
| Financing Activities | 10 | 11 | 23 |
| Net Cash Flow | 0 | 1 | 0 |
Sanjivani Paranteral Shareholding Pattern Screener
See Sanjivani Paranteral shareholding pattern with promoter, FII, and DII holdings. Check Sanjivani Paranteral promoter holding and ownership changes for SANJIVIN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 31.56%, foreign institutions 0.00%, domestic institutions 5.45% and the public 49.92%, spread across 5,880 shareholders.
The shareholder count was 5,880 in 2026-Jun, compared with 5,933 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 31.56% | 31.26% | 31.20% | 31.20% | 28.87% | 28.87% | 27.67% | 27.67% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 5.45% | 6.04% | 6.04% | 6.03% | 6.15% | 6.15% | 6.25% | 6.25% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.92% | 50.05% | 51.06% | 50.99% | 52.60% | 52.43% | 54.08% | 53.90% |
| Other Holding | 13.06% | 12.66% | 11.70% | 11.78% | 12.38% | 12.54% | 11.99% | 12.18% |
| Shareholder Count | 5,880 | 5,933 | 6,017 | 6,307 | 6,429 | 6,447 | 6,618 | 6,731 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sanjivani Paranteral. Sanjivani Paranteral dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.50 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.38% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sanjivani Paranteral Stock Index Membership - Nifty & Sensex
See which indices include Sanjivani Paranteral stock. Check SANJIVIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Sanjivani Paranteral Market Events Screener - Corporate Actions
Get Sanjivani Paranteral corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sanjivani Paranteral stock events that may affect SANJIVIN share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 16, 2026, with a record date of September 16, 2026.
It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 14, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-16 | 2026-09-16 | Annual General Meeting | NA | -8.32% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | -0.91% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -5.69% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 24.37% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.28% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | 10.60% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 0.50 /share | 12.66% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 1.05% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -1.67% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -4.99% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -5.46% |
| 2024-09-24 | 2024-09-24 | Annual General Meeting | NA | 23.26% |
| 2024-01-18 | 2024-01-18 | Extraordinary General Meeting | NA | 0.36% |
Sanjivani Paranteral Competitors Screener - Peer Stocks Comparison
Screen SANJIVIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,010 | 35.84 | 61,674 | 12.69% | 11,565 | 33.78 |
| Divis Laboratories | 244,125 | 84.36 | 11,067 | 13.95% | 2,568 | 49.73 |
| Torrent Pharmaceuticals | 181,512 | 84.01 | 13,886 | 20.34% | 2,138 | 41.48 |
| Zydus Life Science | 113,616 | 24.88 | 27,658 | 17.64% | 5,026 | 46.18 |
| Cipla | 107,890 | 32.42 | 29,045 | 2.24% | 3,870 | 32.87 |
| Laurus Labs | 106,517 | 98.56 | 6,868 | 22.01% | 890 | 56.11 |
| Mankind Pharma | 102,394 | 50.48 | 14,636 | 14.85% | 1,938 | 55.53 |
| Dr Reddys Laboratories | 100,412 | 31.47 | 35,059 | 3.90% | 4,158 | 52.91 |
| Aurobindo Pharma | 96,370 | 25.97 | 34,145 | 5.56% | 3,503 | 49.89 |
| Lupin | 91,961 | 16.71 | 29,039 | 26.75% | 5,356 | 29.12 |
Sanjivani Paranteral Company Announcements - News & Reports Screener
Screen SANJIVIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated September 30, 2026 and September 23, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-30 | Closure of Trading Window | - |
| 2026-09-23 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Clarification Regarding Objects Of The Issue | - |
| 2026-09-16 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-16 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-24 | Record Date For AGM | - |
| 2026-08-24 | Book Closure For AGM | - |
| 2026-08-24 | Notice Of AGM For 2025-26 | - |
| 2026-08-24 | Reg. 34 (1) Annual Report. | - |
| 2026-08-24 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-24 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th August 2026 | - |
| 2026-08-14 | Financials Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-10 | Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday 14Th August 2026 Pursuant To Regulation 29(1)(A) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-23 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹165.95, within a 52-week range of ₹129.30 to ₹239.65. The P/E ratio is 27.20 and the P/B ratio is 4.20, with earnings per unit of ₹5.49. Market capitalisation stands at ₹211.77 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 3 balance sheet periods, 11 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.